Table 3C.
Treatment category | Crude | Adjusted I | Adjusted II | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Systolic | Diastolic | Systolic | Diastolic | Systolic | Diastolic | ||||||||
n | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | |
24h-ABPM | |||||||||||||
Low | 15 | 2.316 | −4.095 to 8.726 | −0.63 | −4.953 to 3.693 | 2.21 | −4.332 to 8.752 | −0.601 | −5.016 to 3.814 | 2.212 | −4.515 to 8.939 | −0.55 | −5.08 to 3.98 |
Moderate | 8 | 5.589 | −1.914 to 13.092 | 1.852 | −3.209 to 6.912 | 5.534 | −2.074 to 13.142 | 1.867 | −3.268 to 7.0 | 5.706 | −2.331 to 13.744 | 1.908 | −3.504 to 7.32 |
High | 9 | 3.722 | −3.536 to 10.98 | 0.948 | −3.947 to 5.843 | 3.654 | −3.712 to 11.02 | 0.966 | −4.005 to 5.938 | 3.607 | −4.016 to 11.231 | 1.108 | −4.025 to 6.242 |
Daytime-ABPM | |||||||||||||
Low | 15 | 1.972 | −4.919 to 8.862 | −1.387 | −5.915 to 3.141 | 1.785 | −5.238 to 8.807 | −1.246 | −5.858 to 3.366 | 1.764 | −5.437 to 8.965 | −1.177 | −5.902 to 3.548 |
Moderate | 8 | 4.064 | −4.001 to 12.13 | 0.404 | −4.896 to 5.705 | 3.966 | −4.201 to 12.132 | 0.479 | −4.885 to 5.842 | 4.351 | −4.254 to 12.955 | 0.617 | −5.029 to 6.262 |
High | 9 | 3.951 | −3.851 to 11.753 | 0.177 | −4.95 to 5.304 | 3.832 | −4.076 to 11.739 | 0.267 | −4.925 to 5.46 | 3.652 | −4.509 to 11.813 | 0.433 | −4.922 to 5.787 |
Nighttime-ABPM | |||||||||||||
Low | 14 | −0.495 | −7.143 to 6.150 | −3.920 | −8.003 to 0.162 | −0.336 | −7.110 to 6.438 | −3.540 | −7.538 to 0.458 | −0.262 | −7.153 to 6.628 | −3.579 | −7.648 to 0.491 |
Moderate | 6 | 5.728 | −2.645 to 14.102 | 1.860 | −3.28 to 7.003 | 5.748 | −2.733 to 14.229 | 1.908 | −3.073 to 6.914 | 6.083 | −2.672 to 14.839 | 1.739 | −3.431 to 6.910 |
High | 6 | 1.492 | −6.881 to 9.866 | 0.150 | −4.992 to 5.293 | 1.588 | −6.050 to 10.080 | 0.378 | −4.638 to 5.390 | 2.255 | −6.482 to 10.981 | −0.112 | −5.171 to 5.148 |
Office BP | |||||||||||||
Low | 15 | 4.65 | −7.425 to 16.725 | −0.517 | −7.847 to 6.813 | 4.645 | −7.653 to 16.942 | −0.311 | −7.752 to 7.131 | 4.507 | −8.053 to 17.067 | −0.29 | −7.906 to 7.327 |
Moderate | 10 | −0.217 | −13.567 to 13.133 | −6.283 | −14.387 to 1.82 | −0.219 | −13.744 to 13.307 | −6.205 | −14.389 to 1.979 | −1.139 | 15.431 to 13.153 | −6.567 | −15.233 to 2.1 |
High | 8 | −0.042 | −14.273 to 14.189 | −4.708 | −13.347 to 3.93 | −0.044 | 14.467 to 14.379 | −4.606 | −13.333 to 4.122 | −0.96 | −15.955 to 14.035 | −4.616 | −13.71 to 4.477 |
Crude, treatment category of sodium bicarbonate: low (1–37.9 mg/kg/day), moderate (38–79.9 mg/kg/day), and high (≥80 mg/kg/day) vs. no treatment (reference); Adjusted I, Crude + change of eGFR from baseline to week 8 (mL/min per 1.73 m2); Adjusted II, Adjusted I + increase and decrease of antihypertensive medication vs. no change of antihypertensive medication.
24h-ABPM, 24 h ambulatory blood pressure monitoring; Daytime ABPM, from 8:00 until 22:00 ambulatory blood pressure monitoring; Nighttime ABPM, from 22:01 until 7:59 ambulatory blood pressure monitoring; Office BP, office blood pressure measurement; β, point estimate (mmHg); 95% CI, 95 % confidence interval.